Topical nepafenac in the treatment of center involving diabetic macular edema

TNOA Journal of Ophthalmic Science and Research

卷:57

关键词: center-involving diabetic macular edema;    foveal thickness;    nepafenac;    prostaglandins;   

DOI  :  10.4103/tjosr.tjosr_12_19

来源: DOAJ

【 摘 要 】

Purpose: To assess the efficacy of topical nepafenac 0.1% in the treatment of center-involving diabetic macular edema (DME). Design: A prospective, interventional case series. Methods: Fourteen eyes of thirteen patients with center-involving DME were included in the study, and they were administered topical nepafenac eye drops 0.1% thrice daily, for 6 months. Vision and foveal thickness were recorded at the baseline and 2nd, 4th, and 6th month follow-up visits. Results: The mean baseline and final LogMAR visual acuity were 0.35 and 0.18, respectively, and the mean baseline and final foveal thickness were 463.4 μm and 291.8 μm, respectively, both showing a statistically significant improvement (P < 0.05). Conclusion: Topical nepafenac is effective in the treatment of center-involving DME in this small case series; however, a large randomized study is warranted.

【 授权许可】

Unknown